Evidence map›Paper›PMID 33051192›Full record

ArticleESMO open2020

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field.

Maximilian Marhold, Thais Topakian, Hermine Agis, Rupert Bartsch, Anna S Berghoff, Thomas Brodowicz, Thorsten Fuereder, Aysegül Ilhan-Mutlu, Barbara Kiesewetter, Michael Krainer and 9 more

Open access · goldAbstract read
In one paragraph

Article in ESMO open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. A real-world study of the quality of Outpatient Pain Management in patients with Cancer.Journal of cancer survivorship : research and practice · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Maximilian MarholdDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria. Electronic address: maximilian.marhold@meduniwien.ac.at.
Thais TopakianDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Hermine AgisDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Rupert BartschDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Anna S BerghoffDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Thomas BrodowiczDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Thorsten FuerederDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Aysegül Ilhan-MutluDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Barbara KiesewetterDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Michael KrainerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Gottfried J LockerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Christine MarosiDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Gerald PragerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Manuela SchmidingerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Christiane ThallingerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Sabine Zöchbauer-MüllerDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Markus RadererDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Matthias PreusserDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Wolfgang LammDivision of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Medical University of Vienna · ATComprehensive Cancer Center Vienna · ATUniversitätszahnklinik Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNovel treatment modalities like targeted therapy and immunotherapy are currently changing treatment strategies and protocols in the field of medical oncology.

methodsNumbers of patients and patient contacts admitted to medical oncology day clinics of a large European academic cancer centre in the period from 2006 to 2018 were analysed using our patient administration system.

resultsA patient cohort of 9.870 consecutive individual patients with 125.679 patient contacts was descriptively and retrospectively characterised. Mean age was 59.9 years. A substantial increase in both individual patients treated per year (+45.4%; 2006: 1.100; 2018: 1.599) and annual patient contacts (+63.3%; 2006: 8.857; 2018: 14.467) between 2006 and 2018 was detected. Hence and most interestingly, the ratio of visits per patient increased by approximately one visit per patient per year over the last 12 years (+12.4%; 2006: 8.0; 2018: 9.0). Further, a decrease of patient contacts in more prevalent entities like breast cancer was found, while contacts for orphan diseases like myeloma and sarcoma increased substantially. Interestingly, female patients showed more per patient contacts as compared with men (13.5 vs 11.9). Lastly, short-term safety data of outpatient day clinic admissions are reported.

conclusionsWe present a representative and large set of patient contacts over time that indicates an increasing load in routine clinical work of outpatient cancer care. Increases observed were highest for orphan diseases, likely attributed to centralisation effects and increased treatment complexity.

Indexed as

NeoplasmsOutpatientsAmbulatory Care FacilitiesFemaleHumansMaleMedical OncologyMiddle AgedRetrospective Studiescancer treatmentchemotherapyoncologyoutpatient treatmenttargeted therapy

Identifiers

PMID33051192
PMCPMC7555099
OpenAlexW3092047075

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.